# FDA Inspection 1302466 - BBS Enterprises, DBA Complexus Medical - February 04, 2026

Source: https://www.keypedia.com/records/fda_inspections/bbs-enterprises-dba-complexus-medical/7fb0d9e4-0b85-4899-a8b9-a2bceb3cfb28
Source feed: FDA_Inspections

> FDA Inspection 1302466 for BBS Enterprises, DBA Complexus Medical on February 04, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302466
- Company Name: BBS Enterprises, DBA Complexus Medical
- Inspection Date: 2026-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Office Name: Detroit District Office

## Related Documents

- [FDA Inspection 1302466 - 2026-02-04](https://www.keypedia.com/records/fda_inspections/bbs-enterprises-dba-complexus-medical/9a07c4e0-ddf2-4528-b377-8922e7194c18)
- [FDA Inspection 1302466 - 2026-02-04](https://www.keypedia.com/records/fda_inspections/bbs-enterprises-dba-complexus-medical/31759625-2a5d-4cce-a8e7-6b4ab3492016)
- [FDA Inspection 1302466 - 2026-02-04](https://www.keypedia.com/records/fda_inspections/bbs-enterprises-dba-complexus-medical/e0b55de6-c31a-42f2-8308-587bd7d51d0a)
- [FDA Inspection 1203308 - 2023-04-12](https://www.keypedia.com/records/fda_inspections/bbs-enterprises-dba-complexus-medical/23c85b21-e8e6-469d-b70f-1a32a5f1cbf2)
- [FDA Inspection 1203308 - 2023-04-12](https://www.keypedia.com/records/fda_inspections/bbs-enterprises-dba-complexus-medical/90412200-75ba-4281-bedb-cd1a7426fe23)

Company: https://www.keypedia.com/companies/bbs-enterprises-dba-complexus-medical/81108c73-1c94-4b9c-a7c2-b48ae35c960d

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03